Simeprevir with pegylated interferon alfa 2a or 2b plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-2): a randomised, double-blind, placebo-controlled phase 3 trial. [electronic resource]
Producer: 20140818Description: 414-26 p. digitalISSN:- 1474-547X
- Adolescent
- Adult
- Aged
- Antiviral Agents -- administration & dosage
- Double-Blind Method
- Drug Administration Schedule
- Drug Therapy, Combination
- Female
- Genotype
- Hepacivirus -- genetics
- Hepatitis C, Chronic -- drug therapy
- Heterocyclic Compounds, 3-Ring -- administration & dosage
- Humans
- Interferon alpha-2
- Interferon-alpha -- administration & dosage
- Male
- Middle Aged
- Polyethylene Glycols -- administration & dosage
- Recombinant Proteins -- administration & dosage
- Ribavirin -- administration & dosage
- Simeprevir
- Sulfonamides -- administration & dosage
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.